05.12.2012 Views

ACC Annual Report - Abramson Cancer Center

ACC Annual Report - Abramson Cancer Center

ACC Annual Report - Abramson Cancer Center

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

12<br />

R ALPH J. & SUZANNE ROBERTS AND BRIAN L. & AILEEN ROBERTS<br />

PARTNER WITH THE MOST COMPREHENSIVE PROTON THERAPY CENTER<br />

PENN Medicine is beginning construction of the Roberts Proton Therapy <strong>Center</strong> – the world’s first fully integrated<br />

proton therapy facility. The Roberts Proton Therapy <strong>Center</strong> is named in honor of Ralph J. and Suzanne Roberts<br />

and Brian L. and Aileen Roberts, who generously pledged $15 million to help create this facility that will treat up<br />

to 3,000 patients a year. Ralph J. Roberts and his son, Brian L. Roberts are both University of Pennsylvania alumni.<br />

“Philadelphia and The University of Pennsylvania have always been special to our family,” said Ralph J. Roberts.<br />

“Suzanne and I are delighted to have the opportunity to give back to these two communities that have meant so<br />

much to us, with a gift that gives life through groundbreaking cancer research and treatment.” Aileen Roberts<br />

remarked that “proton therapy as a treatment for cancer will undoubtedly touch thousands of lives,<br />

both adults and children, and we are fortunate to be a part of that process.”<br />

STEPHEN M. HAHN, M.D.<br />

As a radiation and medical oncologist, as well as an NIH-funded researcher, Stephen<br />

M. Hahn, M.D., brings his many skills and talents to lead one of the nation’s<br />

foremost academic radiation oncology departments. As Chairman,<br />

and previously Vice Chair for Research for the Department<br />

of Radiation Oncology, Hahn has led the expansion of the<br />

department’s research base, which has consistently ranked<br />

first or second in NIH funding. Penn’s <strong>Abramson</strong> <strong>Cancer</strong><br />

<strong>Center</strong> is dedicated to comprehensive care and innovative<br />

treatment options. Adding the Roberts Proton Therapy <strong>Center</strong> to<br />

our repertoire of leading-edge treatments will offer hope and improve<br />

the long-term quality of life for thousands of kids and adults with cancer.<br />

THE RAYMOND<br />

AND RUTH PERELMAN<br />

CENTER FOR<br />

ADVANCED MEDICINE<br />

The Raymond and Ruth Perelman <strong>Center</strong><br />

for Advanced Medicine continues to remain<br />

on schedule for a summer 2008 opening as<br />

the new outpatient facility for the <strong>Abramson</strong> <strong>Cancer</strong><br />

<strong>Center</strong>. The changes in the past few months have been dramatic, and<br />

watching the building come to life has been a wonderful experience<br />

for patients, families and staff alike.<br />

In April, the “topping out” of the building occurred as the final beam<br />

was welded into place. Facing Civic <strong>Center</strong> Boulevard, this beam will<br />

be a visible reminder of the hard work and dedication that have made<br />

the Perelman <strong>Center</strong> possible.<br />

Due to the incredible naming gift of $25 million by Raymond and<br />

Ruth Perelman and the support shown by other donors, our shared<br />

vision to create the most patient-centered, advanced medical facility<br />

possible today is being accomplished. It is incredibly inspiring to see<br />

this emerging building and realize that one day soon this will be the<br />

place people from around the world will come to be cured.<br />

Alliance for <strong>Cancer</strong> Gene Therapy<br />

Barbara and Edward Netter (Penn ‘53) co-founded<br />

Alliance for <strong>Cancer</strong> Gene Therapy (ACGT), the only<br />

public charity dedicated exclusively to cancer gene<br />

therapy research. In six years, ACGT has awarded<br />

30 national grants ($18+ million), including support<br />

for innovative research conducted by Drs. George<br />

Coukos, Carl June and Robert Vonderheide.<br />

Canary Foundation<br />

Don Listwin founded the Canary Foundation in<br />

2004 with a commitment to assisting the next<br />

generation of cancer fighters on the frontlines<br />

of early detection research. The University of<br />

Pennsylvania is proud to be one of eight research<br />

partners, and the Foundation has generously<br />

supported the research efforts of Dr. George Coukos<br />

on the early detection of ovarian cancer.<br />

Evelyn Lauder and<br />

The Breast <strong>Cancer</strong> Research<br />

Foundation (BCRF)<br />

Since 1993, BCRF has raised<br />

over $190 million for breast<br />

cancer research, including<br />

over $5 million in support of<br />

the <strong>Abramson</strong> <strong>Cancer</strong> <strong>Center</strong>.<br />

In 2007, BCRF supported<br />

Drs. Lewis Chodosh, Kate Nathanson, Mark Greene,<br />

Robert Vonderheide, Susan Domchek and Larry<br />

Solin in their research ranging from identifying<br />

breast cancer risks to new therapies.<br />

Independence Blue Cross<br />

Independence Blue Cross (IBC) made a generous<br />

gift to support an endowed chair named in honor<br />

of John H. Glick, M.D. This gift reflects IBC’s deep<br />

appreciation for the care given to G. Fred DiBona,<br />

the former CEO of IBC, who bravely battled renal<br />

cancer. The Glick Chair will bolster Penn’s ability<br />

to continue to recruit top oncologists.<br />

13

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!